FectoPRO is a transfection reagent specifically optimized for transient protein and antibody expression in CHO and HEK293 cells.
Join experts from upstream solutions provider, Polyplus® and contract manufacturing and development organization, EXOTHERA, for a discussion around the importance of focusing on future capacity requirements and capabilities from the start, whilst also bearing patientsafety and patient access well in mind.
Participants: Hanna P. Lesch Ph.D., Chief Technology Officer, Exothera and Julien DEPOLLIER Ph.D., Scientific Support Specialist at Polyplus.
Attend this webinar to learn more about:
✔️Bioprocess economics, scalability, and regulatory compliance
✔️Securing your manufacturing through in-house or outsourcing strategies
✔️Collaboration and innovation to treat more patients